IMIDEX Announces FDA 510k Clearance for VisiRad XR an AIpowered medical device to help

DENVER, Aug. 17, 2023 (GLOBE NEWSWIRE) — IMIDEX, a leader in developing AI-based solutions to address lung cancer, announces that it has received FDA 510(k) clearance for its flagship VisiRad XR product. VisiRad XR is an AI-powered software that analyzes chest X-rays and highlights possible lung nodules and masses. Employing…Read More